| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide an isooxazolyl urea compound having an activity of inhibiting RAF kinase, useful in treating solid cancer, for example a cancerous tumor [such as a cancerous tumor of a lung, spleen, thyroid, bladder, or colon, or a disease of bone marrow (bone marrow leukemia for example)], or an adenoma (a villus-like colon adenoma, for example), or the like. <P>SOLUTION: The compound is represented by the following formula (in the formula, R1 is selected from the group consisting of 3-10C alkyl, 3-10C cycloalkyl, 3-10C halosubstituted alkyl up to perhaloalkyl and 3-10C halosubstituted cycloalkyl up to perhalocycloalkyl, and B represents phenyl, phenyl substituted with pyridyl or -Y-Ar, pyridinyl, indolinyl, isoquinolinyl, quinolinyl or naphthyl). <P>COPYRIGHT: (C)2010,JPO&INPIT</p> |
